Omicia has launched Opal Clinical, a software solution for diagnostic testing. The software includes algorithms for interpreting next-generation sequencing data, including gene panels, exomes, and whole-genomes. The software is both HIPAA and CLIA compliant and can be integrated with LIMS and electronic health records.
Genetworx has launched its Personal Health Panel, a next-generation sequencing-based test to detect pathogens that cause infectious diseases such as sexually transmitted diseases and viruses that infect the gastrointestinal tract. It will also detect pathogens that are resistant to common drugs.